Pliant Therapeutics PLRX
NASDAQ PLRX
$1.15 +0.03 (+3.14%)
As of: Aug 21, 2026 · 2:25 PM EDT

Pliant Therapeutics (PLRX) EBIT Margin Growth (3y) (2023)

Pliant Therapeutics (PLRX) EBIT Margin Growth (3y) (2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.89 Bn 131.04 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.05 Bn 78.06 Bn 3.93 Bn -204.00
3 Argenx Se 65.56 Bn 60.38 Bn 1.37 Bn -537.00
4 Moderna 55.46 Bn 50.32 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 42.12 Bn 37.02 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn 9,003.00
7 BioNTech SE 27.70 Bn 9.30 Bn 668.28 Mn -11,254.00
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.38 Bn 26.54 Bn - -2,649.00
10 Pliant Therapeutics 71.21 Mn 71.21 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -1.86 Mn
Mar 31, 2023 -319,833.00